Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;73(9):2819-2827.
doi: 10.1111/jgs.70005. Epub 2025 Jul 12.

The Trajectories of Neuromuscular Aging (TRAJECTOR-AGE Clinical Trial): Study Rationale and Methodological Protocol

Fulvio Lauretani  1   2 , Marcello Maggio  1   2 , Andrea M Pilotto  3 , Massimiliano Ansaldo  3 , Clarissa M Brusco  4 , Marco Carbonaro  5 , Caterina Amendola  6 , Marco Nabacino  7 , Crescenzo Testa  1   2 , Andrea Ciuni  2   8 , Nicola Sverzellati  2   8 , Irene Zucchini  1 , Marco Salvi  1 , Alfonso Mastropietro  6 , Rebecca Re  7   9 , Alberto Botter  5 , Martino V Franchi  4 , Simone Porcelli  3   10
Affiliations

The Trajectories of Neuromuscular Aging (TRAJECTOR-AGE Clinical Trial): Study Rationale and Methodological Protocol

Fulvio Lauretani et al. J Am Geriatr Soc. 2025 Sep.

Abstract

Objectives: To examine the structural, metabolic, and functional trajectories of neuromuscular decline in aging and identify key mechanisms and early biomarkers to guide interventions preserving function and independence.

Design: The TRAJECTOR-AGE project is a prospective, longitudinal cohort study conducted over 2 years across multiple centers in Italy.

Setting and participants: Community-dwelling, physically and cognitively healthy middle-aged (50-60 years) and older (> 70 years) adults are recruited. Individuals with significant comorbidities (e.g., diabetes, neurological disorders, severe heart failure) are excluded.

Measurements: Participants undergo comprehensive clinical and physiological evaluations every 6 months, including assessments of geriatric status, body composition, cardiovascular function, and neuromuscular performance. Imaging includes periodic quadriceps ultrasound and annual multiparametric MRI to assess muscle volume and fat infiltration. Biological samples (blood, urine and Vastus lateralis muscle biopsy) are collected yearly to evaluate inflammatory, metabolic, and neuromuscular biomarkers.

Expected results: By integrating clinical, functional, and molecular data over time, the TRAJECTOR-AGE study aims to clarify the pathophysiological mechanisms underlying neuromuscular decline, capture inter-individual variability, and explore the influence of habitual physical activity on aging trajectories.

Conclusions: This multidimensional approach may enable earlier identification of individuals at risk for functional decline and inform the development of targeted preventive or therapeutic interventions to promote independence and healthy aging.

Keywords: cognitive frailty; motor function; muscle aging; neuromuscular decline; physical frailty.

PubMed Disclaimer

References

    1. World Health Organization, “Global Health Estimates: Life Expectancy and Leading Causes of Death and Disability,” (2023).
    1. M. Tieland, I. Trouwborst, and B. C. Clark, “Skeletal Muscle Performance and Ageing,” Journal of Cachexia, Sarcopenia and Muscle 9, no. 1 (2018): 3–19.
    1. R. Cooper, D. Kuh, and R. Hardy, “Objectively Measured Physical Capability Levels and Mortality: Systematic Review and Meta‐Analysis,” BMJ (Clinical Research Ed.) 341 (2010): c4467.
    1. F. Landi, R. Calvani, M. Tosato, et al., “Sarcopenia as the Biological Substrate of Physical Frailty,” Clinics in Geriatric Medicine 31, no. 3 (2015): 367–374.
    1. K. R. Short, M. L. Bigelow, J. Kahl, et al., “Decline in Skeletal Muscle Mitochondrial Function With Aging in Humans,” Proceedings of the National Academy of Sciences of The United States of America 102, no. 15 (2005): 5523–5618.

LinkOut - more resources